Virology Specimen Collection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

The Virology Specimen Collection Market was valued at USD 6.50 Billion in 2024, and is expected to reach USD 8.47 Billion by 2030, rising at a CAGR of 4.51%. The market is being propelled by advancements in specimen collection technologies such as immunoassays, nucleic acid amplification techniques, PCR methods, mass spectrometry, and next-generation sequencing (NGS), all aimed at delivering fast and accurate diagnostics for various viral infections. In addition, increasing investment in research and development within the pharmaceutical and biopharmaceutical sectors is further driving demand. The growing focus on large molecule drug development in biopharmaceuticals is also contributing to the market’s expansion over the coming years.

Key Market Drivers

Rising Global Burden of Viral Infections

The growing prevalence and recurrence of viral infections worldwide are key factors accelerating the virology specimen collection market. Conditions such as HIV, hepatitis, influenza, respiratory syncytial virus (RSV), and the recent emergence of COVID-19 necessitate reliable diagnostic practices that begin with high-quality specimen collection. According to the World Health Organization (WHO), seasonal influenza alone causes between 290,000 and 650,000 respiratory deaths annually. Additionally, WHO’s 2023 hepatitis report revealed that 254 million people are living with chronic hepatitis B and 50 million with hepatitis C. These figures highlight the critical need for ongoing viral load testing and effective sample collection protocols to support timely diagnosis and treatment.

Key Market Challenges

Quality Control and Standardization Issues

Ensuring consistent quality and standardization in specimen collection across varied environments presents a significant challenge, particularly in low-resource or high-demand outbreak situations. Accurate diagnostic outcomes depend on the integrity of the specimen from collection to analysis, which can be compromised by inconsistent handling procedures, equipment variation, and lack of trained personnel. Although global agencies like WHO and CDC have outlined standard operating procedures, adherence remains uneven - especially in community-level or decentralized settings. For instance, WHO's guidance during the COVID-19 pandemic stressed that improper specimen collection contributed to false-negative results, even in high-income countries. Challenges such as incorrect swab usage or inadequate temperature control during transport can severely impact diagnostic reliability.

Key Market Trends

Automation and Digitalization in Specimen Handling

A key trend reshaping the virology specimen collection market is the adoption of automation and digital tools in specimen management. Automated systems reduce manual errors, maintain sample integrity, and streamline the overall process from collection to analysis. Technologies such as barcoded specimen tubes, automated swab collection, electronic order entry, and laboratory information management systems (LIMS) are enhancing operational efficiency. These innovations ensure chain-of-custody, improve tracking, and minimize contamination risks. During the COVID-19 crisis, digital health platforms enabled home-based sample collection and automatic result reporting to centralized databases, illustrating the scalability and effectiveness of integrated tech-enabled solutions in virology diagnostics.

Key Market Players

• Becton, Dickinson and Company
• Quidel Corporation
• Thermo Fisher Scientific Inc.
• Trinity Biotech PLC
• Titan Biotech Ltd.
• DiaSorin S.p.A.
• Vircell S.L.
• Copan Italia S.P.A.
• Puritan Medical Products Co.
• Hardy Diagnostics

Report Scope:

In this report, the Global Virology Specimen Collection Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Virology Specimen Collection Market, By Product Type:

• Viral Transport Media
• Specimen Collection Tubes
• Swabs
• Blood Collection Kits

Virology Specimen Collection Market, By Sample:

• Blood Samples
• Cervical Samples
• Nasal Samples
• Nasopharyngeal Samples
• Throat Samples
• Oral Samples
• Other Samples

Virology Specimen Collection Market, By Region:

• North America
• United States
• Mexico
• Canada
• Europe
• France
• Germany
• United Kingdom
• Italy
• Spain
• Asia-Pacific
• China
• India
• South Korea
• Japan
• Australia
• South America
• Brazil
• Argentina
• Colombia
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Virology Specimen Collection Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.